Skip to content
Menu
Ranked #477

Zealthy

Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

Desk Score 51/100 (C) · Verified July 2026

Visit ZealthyAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way.

Is Zealthy legit?

Only what Zealthy publishes and what we could check ourselves — nothing inferred. See the methodology.

FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.

Certification
On third-party certification, the site doesn't say.
Where it ships
34 states, as published on the site.
Last checked
July 2026, against Zealthy's own pages.
Published price
Zealthy publishes a figure for semaglutide and tirzepatide — the qualifiers are in "What does Zealthy cost?" below.
What it sells
Compounded medication only, injectable route only.
Licensing & trust
20/100 on the scored dimension of that name — one of the six in our published methodology.

Proceed with care: an FDA warning letter to this company is on the public record. It is a disclosure rather than a disqualification — the letter is linked above, and it is worth reading before you decide.

What does Zealthy cost?

Each figure exactly as Zealthy publishes it, with the condition attached to it spelled out.

Semaglutide

$286/mo (starting dose, plus a separate fee, compounded)

That is a starting figure, not the price at every dose: $286 a month is the lowest rung, and the cost rises from there.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for semaglutide — only flat month-to-month rates compete there.

Tirzepatide

$351/mo (starting dose, plus a separate fee, compounded)

That is a starting figure, not the price at every dose: $351 a month is the lowest rung, and the cost rises from there.

Because that figure carries a condition, it is held out of our "cheapest" rankings and out of the median we compute for tirzepatide — only flat month-to-month rates compete there.

All figures as published on Zealthy's own site and read in July 2026. Prices change — confirm before you order.

Semaglutide
From $286/molowest dose rung
Tirzepatide
From $351/molowest dose rung
Coverage
34 states
Brand-name
Compounded only
Verification
Prices as published on Zealthy's site — verified july 2026. Each figure's full condition is in “What does Zealthy cost?” below.

Weigh Zealthy against the full ranked field on the best semaglutide providers ranking, or line it up against its closest alternatives. Or go one-on-one: Zealthy vs CoreAge Rx. Because Zealthy dispenses compounded medication, it’s worth understanding whether compounded GLP-1 is legit and safe.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency20/100
State access66/100
Molecule range66/100
Onboarding speed72/100
Support responsiveness69/100
Licensing & trust20/100

What we like

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

Where points come off

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued FitRX, LLC dba Zealthy a warning letter in September 2025; the letter is public in FDA's warning-letter database

The bottom line — C

Best for: Not currently recommended — listed for transparency and reader awareness only.

Zealthy ranks #477 of 542 providers scored — see #1, CoreAge Rx here.

FDAWarning letter issued to FitRX, LLC dba Zealthy in September 2025. See the FDA warning-letter database.

Related reviews

Everyone else here (18)

Pricing and verification reflect Zealthy's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.

← Back to the ranking